ALNY Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Alnylam Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 265.75 USD 0.47% Market Closed

Market Cap: $35.5B

	Alnylam Pharmaceuticals Inc NASDAQ:ALNY	US
W	Walt Disney Co XMUN:WDP	US
D	Deutsche Boerse AG DUS:DB1	DE
W	Waters Corp DUS:WAZ	US
	Vita Coco Company Inc F:85E	US
F	First Tin PLC LSE:1SN	UK
B	Barnes Group Inc F:BG4	US

Profitability Summary

Alnylam Pharmaceuticals Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

80%

Strong 3Y Average Gross Margin

84%

Declining Gross Margin

81% > 80%

Healthy Operating Margin

20%

Negative 3Y Average Operating Margin

-1%

Operating Margin is Increasing

-73% > 20%

Healthy Net Margin

17%

Negative 3Y Average Net Margin

-7%

Net Margin is Increasing

-86% > 17%

Exceptional Free Cash Flow Margin

17%

Sustainable 3Y Average Free Cash Flow Margin

Free Cash Flow Margin is Increasing

-44% > 17%

Exceptional ROE

101%

Exceptional 3Y Average ROE

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.